MedPath

A study to compare the effect of dexmedetomidine versus ketamine in fracture femur patients

Phase 3
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2022/05/042695
Lead Sponsor
izams Institute of medical sciences Hyderabad India
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Patients of either sex

2)Patients with ASA grade 1 and grade 2

3)Patients aged between 18 to 65 years

4)Patients with femur fractures

Exclusion Criteria

1)Refusal to participate in the study

2)Peripheral neuropathy

3)Patients having coagulation or bleeding abnormalities

4)Local site infection

5)Altered mental status

6)Patients with significant coexisting diseases like ischemic heart disease, impaired renal function and severe liver disease

7)Patients on beta blockers

8)Patients allergic to bupivacaine, dexmedetomidine, ketamine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare postoperative analgesia and duration of analgesia after fracture <br/ ><br>femur surgery in dexmedetomidine versus ketamine groupTimepoint: 1 year
Secondary Outcome Measures
NameTimeMethod
cumulative analgesic requirements, hemodynamic effects, side effectsTimepoint: 1 year
© Copyright 2025. All Rights Reserved by MedPath